PARIS, Feb. 25, 2020 /PRNewswire/ — This new beta DNA matching service allows everyone to upload the raw data of a DNA test kit taken from any company, and to compare it to other Geneanet members’ DNA data for finding new relatives. Completely free of charge, Geneanet DNA supports DNA data from AncestryDNA, 23andMe, MyHeritage, Family Tree DNA and Living DNA. Two persons who have taken a DNA test with two different companies will be able to find they are related thanks to the Geneanet DNA database.
With about 4 million members, more than 1 million family trees and 7 billion indexed individuals, Geneanet is the largest European genealogy database. By proposing this new and free DNA matching service, Geneanet allows its members to get a list of relatives with whom they share DNA sequences, to contact them and to view their family tree for finding their common ancestor.
If you have European ancestors, Geneanet is the most informative and fairly priced genealogy website of all. The Freemium, contributive and collaborative model of Geneanet is appreciated by all the members. They can grow their family tree and have contact with their relatives to share more information about their common family history. The Geneanet team is of great assistance and close to its members.
Based in France, Geneanet respects and complies with the General Data Protection Regulation (GDPR) so the DNA data cannot be used for any other purpose than that accepted by the member. The DNA data remain the property of the member who can remove them at any time and Geneanet does not retain these data anymore.
On February 26-29, 2020, meet the Geneanet team at Rootstech in Salt Lake City, Utah, USA, at booth #417.
Contact:
Océane Simon
oceane@lanouvelle-agence.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/geneanet-the-leading-genealogy-website-in-europe-launches-its-dna-matching-service-301008504.html
SOURCE Geneanet
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…